Rane (Madras) Ltd
RMLRane (Madras) Ltd's earnings have outrun its stock. EPS grew +68.0% in a year against a +60.1% price move.
The sharpest disagreement: Promoters moved −2.2 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced.
The price is in a confirmed uptrend (15 weeks in) while the P/E sits at the 59th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +57.9% year on year, and 363% of the last 3 years' profit arrived as cash. What settles it: whether the register turns back in the story’s favour.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Rane (Madras) Ltd trades at ₹1,360, in a confirmed uptrend and 15 weeks into that stage. That is +38.6% against its own 200-day average. It sits at 100% of a 52-week range of ₹662 to ₹1,360. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 27 straight weeks.
Today the stock is in a confirmed uptrend — week 15 of stage 2, confirmed. At ₹1,360 it trades +38.6% versus its 200-day average and sits at 100% of its 52-week range (₹662–₹1,360).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +339% while the NIFTY 500 moved +264% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 27 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
Rane (Madras) Ltd's story is not scored yet against the markers our research file set on 22 August 2026. Where it sits in its own cycle: MID_EXPANSION. Our fortnightly research layers last read it on 22 August 2026.
Our read, 22 August 2026. Operational turnaround driven by record export program wins, HCL friction integration, and land monetization deleveraging, balanced against legacy steering contract drags and cyclical peak-margin valuation sensitivity.
From the numbers. The stock sits in mid-expansion of its operating earnings cycle. Trailing PE has moderated from peak levels toward 25.2x as earnings expanded. The market reflects an emerging opportunity where volume scale and merger…
From the price. Price stage 2, week 15 — above its 200-day line, relative strength rising.
From the research. Operational turnaround driven by record export program wins, HCL friction integration, and land monetization deleveraging, balanced against legacy steering contract drags and cyclical peak-margin valuation sensitivity.
🚨 Where they disagree. The stock sits in mid-expansion of its operating earnings cycle. Trailing PE has moderated from peak levels toward 25.2x as earnings expanded. The market reflects an emerging opportunity where volume scale and merger synergies counterbalance input cost pressures and legacy steering contract drags.
What is proven. Operational turnaround driven by record export program wins, HCL friction integration, and land monetization deleveraging, balanced against legacy steering contract drags and cyclical peak-margin valuation sensitivity.
What is not proven yet. Consolidated operating EBITDA margin remaining below 8.5% through Q3 and Q4 FY27, combined with net debt failing to decline below 650 Cr due to capex escalation or delays in Velachery land monetization receipts.
🚨 What would change our mind. Consolidated operating EBITDA margin remaining below 8.5% through Q3 and Q4 FY27, combined with net debt failing to decline below 650 Cr due to capex escalation or delays in Velachery land monetization receipts.
Layer 1 read, 22 August 2026 — KEEP. A genuinely clean earnings recovery, but 62% more shares were issued so owners got about a third of the headline growth. For five straight quarters now the profits have been free of accounting noise — pre-tax profit rose from Rs 25 crore to Rs 41 crore while sales passed Rs 1,000 crore three quarters running, and the order book behind it is the largest the company has booked, Rs 712 crore of annualised wins in FY26 plus Rs 2,040 crore of lifetime orders added last quarter, over half of them exports. The catch is that the reported profit jump of 181.6% for FY26 came alongside a share issue: the company's equity capital went from Rs 16 crore to Rs 28 crore during the year, so profit per share grew about 68%, not 181% — and the timeline's own note that share capital was "stable" is simply not what the balance…
What would change Layer 1’s mind. Consolidated operating margin staying below 8.5% through both the September and December 2026 quarters while net debt fails to fall below Rs 650 crore — because the entire case rests on 8-9% margin lifting toward double digits as the 85-90% legacy steering book expires, and if margin does not move while the balance sheet stops deleveraging, the record order book is being bought with capital rather than earned. A second, separate breaker: any further share issue beyond the 40 Cr of preferential…
Layer 2 read, 22 August 2026 — ADVANCE. Export orders have outside sector support, while capital is not yet crowded. RML's record export program wins are hard company evidence, and broad sector commentary supports niche auto-component value-chain gains. The capital-cycle block is neutral rather than a late-cycle flood, so no external veto overturns L1.
What would change Layer 2’s mind. A company-specific external report showing export orders cancelled or delayed, together with consolidated margin staying below 8.5% through Q4 FY27, would flip ADVANCE to DROP.
Layer 3 read, 22 August 2026 — BENCH. Orders are strong, but cost recovery and two revised promises make this too early to fund. The order win beat its target, but management delivered only part of the debt reduction and cut the steering-margin goal. Commodity recovery remains difficult, and the new Rs 370 Cr all-cash acquisition has no funding bridge; the ZF recall does not escalate RML because ICRA places that associate under Rane Holdings.
What would change Layer 3’s mind. Two consecutive quarters with consolidated EBITDA margin below 8.5% and no customer price recovery would escalate commodity risk to HIGH and flip BENCH to DROP.
The test written in advance. Consolidated operating EBITDA margin remaining below 8.5% through Q3 and Q4 FY27, combined with net debt failing to decline below 650 Cr due to capex escalation or delays in Velachery land monetization receipts. — the thesis as written as stated by the next result.
The test written in advance. Input Cost Inflation and Pass-Through Lag — Input Cost Inflation and Pass-Through Lag Consolidated operating EBITDA margin staying below 8.5% in Q2 and Q3 FY27 prints. by the next result.
The test written in advance. Rane Steering Legacy Margin Drag — Rane Steering Legacy Margin Drag Divisional EBITDA margin in Rane Steering failing to exceed 4.5% by Q4 FY27. by the next result.
What the company does. Revenue has scaled past 1,000 Cr per quarter with FY26 new order wins reaching 712 Cr annualized and Q1 FY27 new-business lifetime value at 2,040 Cr (54% exports). EBITDA margins remain constrained at 8.0-9.0% by legacy low-priced steering contracts (85-90% of division revenue) and raw material pass-through lags, with management targeting double-digit EBITDA margin inflection by Q3 FY27. Land monetization proceeds of 360 Cr (145 Cr realized) fund ongoing capex of 270-300 Cr, enabling progressive group net debt reduction toward a 0.5x debt-to-equity target by March 2028.
| Dial | Now | Was | Why it matters | Watch line |
|---|---|---|---|---|
| Export Expansion and Lifetime Value Order… | in play | — | Export mix expanded to 27-28% with Q1 FY27 new-business lifetime value of 2,040 Cr (54% exports) providing multi-year volume… | Global automotive production slows materially or trade barriers penalize Indian component sourcing. |
| HCL Friction Acquisition and Railway… | in play | — | Integration of HCL friction business adds two manufacturing facilities and 40% tender-driven railway revenue exposure with… | Railway capital expenditure tenders face prolonged delays or post-merger integration costs exceed initial estimates. |
| Rane Steering Product Mix Rollover | in play | — | Transition from legacy low-margin contracts (85-90% of revenue) to new programs booked at 8-9% EBITDA margins drives divisional… | Key OEM clients delay new vehicle model launches or raw material indexation fails to cover component inflation. |
| Land Monetization Deleveraging Catalyst | in play | — | Real estate monetization of 360 Cr (145 Cr received) funds capex requirements and targets a 0.5x debt-to-equity ratio by March… | Municipal real estate approvals face extended administrative delays or property developers renegotiate payout milestones. |
🚨 What the surface reading misses. The surface reading is: Trailing PE ratio of 25.2x sits at the median (50th percentile) of 10-year history, suggesting fair valuation relative to historical multiples. The research reads it further: Trailing earnings reflect near-peak operating margins (8.3% vs 10-year normalized 7.5%); at mid-cycle margins, normalized PE rises to 43.4x (87th percentile), creating a peak-margin multiple sensitivity.
🚨 What the surface reading misses. The surface reading is: Operating margin of 8.3% indicates solid profitability across operating divisions. The research reads it further: Current OPM sits at the 67th percentile of its historical range (-29.3% to 10.2%), driven by volume recovery but still constrained by legacy steering contracts and input cost pass-through lags.
Lever 2 · Value-added mix — BUILDING. Export mix expanded to 27-28% with Q1 FY27 new-business lifetime value of 2,040 Cr (54% exports) providing multi-year volume runway. What proves it keeps working: Export Expansion and Lifetime Value Order Pipeline. It stops working if Global automotive production slows materially or trade barriers penalize Indian component sourcing.
Lever 6 · Order-book wins — BUILDING. Integration of HCL friction business adds two manufacturing facilities and 40% tender-driven railway revenue exposure with margin accretion. What proves it keeps working: HCL Friction Acquisition and Railway Exposure. It stops working if Railway capital expenditure tenders face prolonged delays or post-merger integration costs exceed initial estimates.
Sources: our stock research file (22 August 2026) · quarterly results through Jun 26 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Rane (Madras) Ltd reported ₹1,042 Cr of revenue in the Jun 26 quarter, +18.3% year on year. That is the 10th straight quarter of year-on-year growth. Over 10 years it has compounded at 16.0% a year. The last full year, FY26, came in at ₹3,863 Cr. The last four reported quarters add to ₹4,024 Cr.
FY26 revenue came in at ₹3,863 Cr (+13.4% on the year), capping 10 years at 16.0% compound. The latest quarter (Jun 26) printed ₹1,042 Cr, +18.3% year on year — the 10th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +16.0% growth against the decade's 16.0% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +16.0% over the last 4 quarters against +19.8%/yr over the last 8 — rolling over; TTM profit +183.3% vs +49.8%/yr — accelerating.
FY26-Q4. revenue ₹1,048 Cr and profit ₹37 Cr as reported.
FY27-Q1. revenue ₹1,042 Cr and profit ₹30 Cr as reported.
Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Rane (Madras) Ltd's operating margin is 8.0% in the Jun 26 quarter, +0.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 11 fiscal years the operating margin has ranged 2.5% to 9.0%. The current quarter sits inside that band.
Why this happened. The completed acquisition of HCL friction complements RML Brake Components division by adding commercial vehicle and railway friction capabilities across two Maharashtra plants. Railways represent approximately 40% of HCL revenue with 12-14 months tender visibility. The business operates at margin-accretive levels relative to standalone RML, providing incremental operating profit as joint procurement, logistics, and formulation synergies materialize over a 12-18 month integration window.
The latest quarter's operating margin is 8.0%, +0.0 pp against the same quarter a year ago. Across 11 fiscal years the operating margin has ranged 2.5%–9.0%, and FY26's 9.0% is the top of that band — a record year.
🚨 Why the margin moved: operating margin went −0.2 pp year on year while gross margin went −2.5 pp — the loss came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
FY26-Q4. revenue ₹1,048 Cr and profit ₹37 Cr as reported.
FY27-Q1. revenue ₹1,042 Cr and profit ₹30 Cr as reported.
Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Rane (Madras) Ltd earned ₹30.0 Cr of net profit in the Jun 26 quarter, +57.9% year on year. It is the 2nd consecutive quarter of growth. Full-year FY26 profit was ₹107 Cr. The 10-year compound rate is 23.5%. That is 2.9% of the quarter's revenue. The same quarter a year earlier earned ₹19.0 Cr.
Jun 26 profit was ₹30.0 Cr, +57.9% year on year — the 2nd consecutive quarter of growth. On the full year, FY26 printed ₹107 Cr (+181.6%), and the 10-year compound rate is 23.5%.
Why profit moved: revenue contributed +18.3% and the margin +0.0 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +172.6% vs revenue +16.0%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
FY26-Q4. revenue ₹1,048 Cr and profit ₹37 Cr as reported.
FY27-Q1. revenue ₹1,042 Cr and profit ₹30 Cr as reported.
Why-sources: our stock research file (22 August 2026) and the company’s own results for those quarters.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 363% of Rane (Madras) Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹219 Cr of operating cash against ₹107 Cr of profit. After ₹215 Cr of capital spending, ₹4.0 Cr was left as free cash.
FY26: operating cash of ₹219 Cr against reported profit of ₹107 Cr, leaving free cash of ₹4.0 Cr after ₹215 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 363% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 363%: the cash cycle stretched 58 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: the bigger cash user is investment — capital spending ran 1.8× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Rane (Madras) Ltd's cash conversion cycle runs 67 days in FY26, up from 9 days in FY21. Capital spending ran ₹726 Cr over the last 3 years. At FY26 sales of ₹3,863 Cr each day of that cycle holds about ₹10.6 Cr, so roughly ₹709 Cr sits inside the business at any moment.
Why this happened. RML has accelerated customer acquisition in international markets, with export revenue reaching 27-28% of mix. The company secured record annualized order wins of 712 Cr in FY26 and added 2,040 Cr of lifetime-value orders in Q1 FY27. With 54% of the new pipeline targeted at export platforms (rack and pinion for European small cars, ball joints, and steering housings), this volume diversification reduces domestic cyclicality and supports operating leverage as new programs ramp up over an 18-24 month gestation period.
FY26: debtors at 75 days, inventory at 80 days — roughly 2.6 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 67 days, looser than FY21's 9.
The full loop: cash goes out to suppliers and production on day 0; stock waits 80 days to sell; customers pay about 75 days after that; and suppliers themselves are paid at 88 days — netting out to the 67-day cycle.
In money terms: at FY26 sales of ₹3,863 Cr, each day of the cycle holds about ₹10.6 Cr — so the 67-day loop keeps roughly ₹709 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹726 Cr over the last 3 fiscal years against ₹411 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹95.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Rane (Madras) Ltd earns a ROCE of 14% in FY26. That is up from a trough of −4% in FY21. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 2.8% net margin on 1.53× asset turns.
FY26 ROCE is 14%, recovered from a FY21 trough of −4% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 2.8% net margin × 1.53× asset turns × 3.36× balance-sheet leverage ≈ 14.4% on equity. Margin does its share; leverage is a meaningful part of the equation.
The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 395% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Rane (Madras) Ltd carries ₹752 Cr of borrowings against ₹751 Cr of equity in FY26, a debt-to-equity of 1.00. Operating profit covers the interest bill 6×. Over 5 years borrowings went from ₹470 Cr to ₹752 Cr. Capital spending ran ₹726 Cr across the last 3 of those years.
Why this happened. RML is executing land monetization across surplus parcels, with the Velachery transaction targeting total receipts of 360 Cr (145 Cr realized to date). These milestone-linked proceeds have allowed the company to self-fund major growth capex (215 Cr in FY26 and 270-300 Cr planned for FY27) while lowering net debt by 73.4 Cr in FY26. Management has set a firm milestone to achieve a group net debt-to-equity ratio of 0.5x by March 2028.
FY26: borrowings of ₹752 Cr against equity of ₹751 Cr — a debt-to-equity of 1.00. Operating profit covers the interest bill 6×. Over 5 years borrowings went from ₹470 Cr to ₹752 Cr while capital spending ran ₹726 Cr in just the last 3 — part of the build-out is riding on borrowed money.
The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 395% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 2.2 points of Rane (Madras) Ltd over 8 quarters, the biggest move on the register. That takes promoters to 70.5% of the company. Domestic institutions moved +0.8 points over the same window, to 0.8%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −2.2 points over 8 quarters to 70.5%; Domestic institutions: +0.8 points over 8 quarters to 0.8%; Foreign institutions: +0.3 points over 8 quarters to 0.3%.
🚨 Why the register moved: promoters drove it (−2.2 points), absorbed on the other side by domestic institutions (+0.8 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Rane (Madras) Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Rane (Madras) Ltd trades at 31.1× P/E, mid-range by its own standards (59th percentile). Its long-run median P/E is 27.8×, measured across 10.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 31.1× is mid-range by its own standards (59th percentile), against a long-run median of 27.8× measured over 10.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +68.0% against a +60.1% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 10y, of the +12.1%/yr price move, ~+12.2%/yr came from earnings growth and ~−0.1 pp from the multiple (roughly flat). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources disagree by up to 395% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 26 August 2026 price, Rane (Madras) Ltd was paying for profit growth of about 16.6% a year. Profit itself has compounded 23.5% a year over the past 10 years. Today the market pays 31.1× P/E, the 59th percentile of its own 10-year range.
What the two numbers say together. The multiple is unremarkable against its own past, and the growth the price is paying for is below what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 26 August 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Rane (Madras) Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −7.8% at the trough to +183.3% off a 3-quarter-old trough, ROCE holding at 14.0%. The read is built from 8 quarters across 4 curves, on partial evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +13.4% | +18.0% | +25.0% | +16.0% |
| Profit | +181.6% | +52.8% | — | +23.5% |
| EPS | +68.0% | +28.2% | — | +12.4% |
| Share price | +60.1% | +23.5% | +28.5% | +12.1% |
4-Factor Sector Score
66.5/100 — rank 1 of 7 in Auto Ancillaries - Gears · 75% evidence confidence
Rane (Madras) Ltd scores 66.5 out of 100 against the 7 companies it is compared with in Auto Ancillaries - Gears, ranking 1. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 26.3 + 12.1 + 11.5 + 16.6 = 66.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Said versus delivered
What Rane (Madras) Ltd's management promised, set against what actually arrived — 4 tracked promises on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.
Deleveraging Target and Timeline Not Reconciled · 21 August 2026. In Aug 2025, management described deleveraging as a current-year objective of reducing debt by about INR150 crores and said debt would continue to come down. In Aug 2026, the stated milestone is reaching a 0.5 debt-to-equity ratio by March 2028, with debt reduction framed over the next 12-18 months. The latest call does not reconcile whether the earlier FY26 reduction target was achieved or explain the transition from a near-term rupee target to a later leverage milestone.
Debt Reduction Target Underperformance · 18 May 2026. During the Aug 2025 call, management stated a specific goal to reduce net debt by 150 crores for Rane Madras over the financial year. However, according to the May 2026 full-year results, the actual debt reduction achieved was only 73.4 crores, representing a significant variance from the stated target.
Rane Steering Margin Guidance Revision · 18 May 2026. In the Aug 2025 call, management projected that new business programs for Rane Steering Systems would generate EBITDA margins of approximately 8%. By the May 2026 call, management lowered this expectation, guiding that the business would only reach a mid-to-high single-digit margin of 5 to 6% in the next two years.
🚨 Debt Reduction Timeline Delay · 17 February 2026. In the August 2025 call, management committed to a 150-crore reduction in debt for Rane (Madras) Ltd. by the end of the current financial year (FY26). However, in the February 2026 call, management admitted that absolute debt has remained flat as land sale proceeds were diverted to fund capital expenditure, and they have pushed the target for substantial debt reduction out by a full year to March 2027. Earlier call (Aug 2025): “INR796 crores is the current debt as on June 30, and since then another INR70 crores, INR75 crores has been paid off. So it will continue to come down. As I said earlier, about INR150 crores is the target during this year.” Later call (Feb 2026): “For absolute debt to come down, it will likely be March FY27. ... Had we not received this land parcel advance money, we would have gone for another 100 crore of debt, which we avoided by using those funds for capex expansion.”
Every quote above is taken word for word from the company’s own earnings calls.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Rane (Madras) Ltdthis pageRML | 66.5/100Favorable setup75% evidence | LEADER | 26.3/35 Revenue 16% · PAT 100% · OPM change 0 pp 95% evidence | 12.1/25 ROCE 14% · OPM 8% 76% evidence | 11.5/20 P/E 31.1× · PEG — 15% evidence | 16.6/20 RS sector 15.7% · RS bench 53.6% · 1Y 61.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 26.3 + 12.1 + 11.5 + 16.6 = 66.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2RACL Geartech LtdRACLGEAR | 64.7/100Mixed-positive evidence87% evidence | BREAKING OUT | 28.7/35 Revenue 28.2% · PAT 78.1% · OPM change 5.4 pp 95% evidence | 16.3/25 ROCE 16.9% · OPM 24.1% 95% evidence | 8.5/20 P/E 41.6× · PEG — 50% evidence | 11.2/20 RS sector 7.4% · RS bench 43.2% · 1Y 92.4%5 of 12 weeks ahead 100% evidence |
| Exact sum: 28.7 + 16.3 + 8.5 + 11.2 = 64.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3Sar Auto Products Ltd538992 | 49.0/100Mixed-negative evidence60% evidence | LEADER | 21.7/35 Revenue 39.9% · PAT 100% · OPM change -4.2 pp 95% evidence | 6.3/25 ROCE 2.1% · OPM 12.6% 76% evidence | 8.5/20 P/E 2820× · PEG — 15% evidence | 12.5/20 RS sector — · RS bench 122.1% · 1Y 165.6%12 of 12 weeks ahead 25% evidence |
| Exact sum: 21.7 + 6.3 + 8.5 + 12.5 = 49 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Z F Steering Gear (India) LtdZFSTEERING | 41.1/100Mixed-negative evidence81% evidence | TURNING | 17.1/35 Revenue 16.4% · PAT 66.7% · OPM change -5 pp 95% evidence | 7.8/25 ROCE 6.5% · OPM 9% 95% evidence | 10.0/20 P/E 34.4× · PEG — 50% evidence | 6.2/20 RS sector -29.6% · RS bench 0.4% · 1Y -28%1 of 10 weeks ahead 70% evidence |
| Exact sum: 17.1 + 7.8 + 10 + 6.2 = 41.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5JTEKT India LtdJTEKTINDIA | 37.0/100Mixed-negative evidence82% evidence | BASING | 16.6/35 Revenue 16.8% · PAT 1.5% · OPM change -0.1 pp 95% evidence | 10.4/25 ROCE 9.8% · OPM 5.3% 76% evidence | 10.0/20 P/E 43.6× · PEG — 50% evidence | 0.0/20 RS sector -35.2% · RS bench -12.9% · 1Y -24.2%2 of 12 weeks ahead 100% evidence |
| Exact sum: 16.6 + 10.4 + 10 + 0 = 37 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Shanthi Gears LtdSHANTIGEAR | 36.4/100Mixed-negative evidence94% evidence | TURNING | 3.5/35 Revenue -16.9% · PAT -34.3% · OPM change -9.5 pp 100% evidence | 18.3/25 ROCE 25.6% · OPM 13.1% 100% evidence | 3.6/20 P/E 81.5× · PEG 3.18 100% evidence | 11.0/20 RS sector -5.4% · RS bench 54.3% · 1Y 26%3 of 10 weeks ahead 70% evidence |
| Exact sum: 3.5 + 18.3 + 3.6 + 11 = 36.4 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 7The Hi-Tech Gears LtdHITECHGEAR | 36.4/100Mixed-negative evidence74% evidence | TURNING | 8.2/35 Revenue 5.5% · PAT -38.6% · OPM change -1.1 pp 95% evidence | 12.8/25 ROCE 6.9% · OPM 11.1% 95% evidence | 9.5/20 P/E 54.1× · PEG — 15% evidence | 5.9/20 RS sector -9.8% · RS bench -12.1% · 1Y -16%0 of 10 weeks ahead 70% evidence |
| Exact sum: 8.2 + 12.8 + 9.5 + 5.9 = 36.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Rane (Madras) Ltd's share price today?
Rane (Madras) Ltd trades at ₹1,360, +60.1% over the past year. The company is valued at ₹3,759 Cr. The stock sits at the very top of its 52-week range (₹662–₹1,360), +38.6% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 15 weeks in. — as of 11 September 2026.
What were Rane (Madras) Ltd's latest quarterly results?
Rane (Madras) Ltd reported revenue of ₹1,042 Cr and net profit of ₹30.0 Cr for the Jun 26 quarter. Revenue rose 18.3% and profit rose 57.9% year on year. Earnings per share were ₹10.89. The operating margin was 8.0%, 0.0 pp higher than a year earlier. — as of 11 September 2026.
What is Rane (Madras) Ltd's revenue?
Rane (Madras) Ltd reported revenue of ₹1,042 Cr in the Jun 26 quarter, +18.3% year on year. For the full FY26 fiscal year, revenue was ₹3,863 Cr (+13.4%). Over the last 10 years revenue compounded at 16.0% a year. — as of 11 September 2026.
What is Rane (Madras) Ltd's profit?
Rane (Madras) Ltd earned ₹30.0 Cr of net profit in the Jun 26 quarter, +57.9% year on year — the 2nd straight quarter of growth. Full-year FY26 profit was ₹107 Cr. The operating margin ran 8.0% in the latest quarter. — as of 11 September 2026.
What is Rane (Madras) Ltd's market cap?
Rane (Madras) Ltd's market capitalisation is ₹3,759 Cr at a share price of ₹1,360. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Rane (Madras) Ltd's P/E ratio?
Rane (Madras) Ltd trades at a P/E of 31.1×, at the 59th percentile of its own 10-year range, against a long-run median of 27.8×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Rane (Madras) Ltd pay a dividend?
Yes — Rane (Madras) Ltd's dividend payout was 41% of profit in FY26, and it recorded a payout in 6 of its last 11 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Rane (Madras) Ltd overvalued?
On its own history, Rane (Madras) Ltd looks mid-range: its P/E of 31.1× sits at the 59th percentile of its 10-year range (long-run median 27.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 11 September 2026.
Is Rane (Madras) Ltd growing?
Yes — Rane (Madras) Ltd is growing: latest-quarter revenue +18.3% year on year, profit +57.9%, and the margin +0.0 pp at 8.0%. The 10-year compound rates are 16.0% (revenue) and 23.5% (profit). The earnings engine currently reads: improving — as of 11 September 2026.
How is Rane (Madras) Ltd performing?
Rane (Madras) Ltd is in a confirmed uptrend, 15 weeks in. Its latest quarter's revenue rose 18.3% and profit rose 57.9% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 27 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Rane (Madras) Ltd in?
Turning around — profit growth swung from −7.8% at the trough to +183.3% off a 3-quarter-old trough, ROCE holding at 14.0%. The read comes from the last 12 quarters of growth (revenue growth +16.0% latest, profit growth +183.3% latest, eps growth +106.5% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Rane (Madras) Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 15 of stage 2), trading +38.6% versus its 200-day average and at the very top of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Rane (Madras) Ltd beating the market?
On recent form, yes — Rane (Madras) Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 27 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +339% against the NIFTY 500's +264% — ahead of the index over the full window. — as of 11 September 2026.
Will Rane (Madras) Ltd's share price go up?
This page publishes no price forecast for Rane (Madras) Ltd. What it measures instead: the share price is ₹1,360, the price is in a confirmed uptrend 15 weeks in. Its P/E of 31.1× sits at the 59th percentile of its own 10-year range. — as of 11 September 2026.
Who owns Rane (Madras) Ltd?
Promoters hold 70.5% of Rane (Madras) Ltd, foreign institutions 0.3%, domestic institutions 0.8% and the public 28.4% (latest quarter). The biggest move on the register over the last two years: Promoters cut 2.2 points over 8 quarters. — as of 11 September 2026.
Does Rane (Madras) Ltd have too much debt?
It is moderate — Rane (Madras) Ltd's debt-to-equity is 1.00, and operating profit covers the interest bill 6×. FY26 borrowings were ₹752 Cr against equity of ₹751 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is Rane (Madras) Ltd's capex?
Rane (Madras) Ltd spent ₹726 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹215 Cr, with ₹95.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Rane (Madras) Ltd's cash flow?
Rane (Madras) Ltd generated ₹219 Cr of operating cash flow in FY26 and ₹4.0 Cr of free cash flow after ₹215 Cr of capital spending. Reported profit that year was ₹107 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Rane (Madras) Ltd's profit real cash?
Yes — over the last 3 fiscal years, 363% of Rane (Madras) Ltd's reported profit arrived as operating cash. Though the latest year ran at 205% — the trend is the thing to watch. In FY26, operating cash was ₹219 Cr against reported profit of ₹107 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Rane (Madras) Ltd in its business cycle?
Rane (Madras) Ltd's FY26 operating margin was 9.0%, against a 11-year band of 2.5%–9.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 8.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Rane (Madras) Ltd's price assume?
At its price on 26 August 2026, Rane (Madras) Ltd was priced for profit growth of about 16.6% a year. Profit itself has compounded 23.5% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Rane (Madras) Ltd story?
The sharpest disagreement: Promoters moved −2.2 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Rane (Madras) Ltd a stock worth studying right now?
This is not investment advice. The machine read: Rane (Madras) Ltd's earnings have outrun its stock. EPS grew +68.0% in a year against a +60.1% price move. The sharpest open question: whether the register turns back in the story’s favour. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!